|
US 6,982,334 B2 |
|
Crystalline form of (3R,4R)-4-[3-(S)-hydroxy-3-(6-methoxyquinolin-4-yl)propyl]-1-[2-(2-thienylthio)ethyl]piperindine-3-carboxylic
acid |
Jacques Bourget, Vitry sur Seine (France); Marc Antoine Perrin, Jouy en Josas (France); Serge Mignani, Chatenay Malabry (France); Bernd Janocha, Wiesbaden (Germany); Michel Cheve, Soisy sur Seine (France); Carole Neves, Paris (France); Pascal Billot, Montreuil (France); Michel Tabart, La Novrille (France); and Sylvaine Lafont, Trevoux (France) |
Assigned to Aventis Pharma S.A., Antony (France) |
Filed on Dec. 18, 2003, as Appl. No. 10/739,700. |
Claims priority of provisional application 60/480412, filed on Jun. 20, 2003. |
Claims priority of application No. 02 16415 (FR), filed on Dec. 20, 2002. |
Prior Publication US 2004/0147751 A1, Jul. 29, 2004 |
Int. Cl. C07D 409/14 (2006.01); C07D 215/20 (2006.01); A61K 31/4709 (2006.01); A61P 31/04 (2006.01)
|